Dietary habits and behaviors associated with nonalcoholic fatty liver disease

World Journal of Gastroenterology

Volumn 20, Issue 7, 2014, Pages 1756-1767

  Yasutake, Kenichiro ^a   Kohjima, Motoyuki ^b   Kotoh, Kazuhiro ^c   Nakashima, Manabu ^d   Nakamuta, Makoto ^b   Enjoji, Munechika ^d  

^a NISHIKYUSHU UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^c KYUSHU UNIVERSITY HOSPITAL   (Japan)

^d FUKUOKA UNIVERSITY   (Japan)

Author keywords

Carbohydrates; Cholesterol; Fatty acids; Nonalcoholic fatty liver disease; Nutritional therapy

Indexed keywords

ALPHA TOCOPHEROL; CARBOHYDRATE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; MINERAL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYUNSATURATED FATTY ACID; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; VITAMIN; FAT INTAKE; FATTY ACID; LIPID; UNSATURATED FATTY ACID;

ALPHA TOCOPHEROL DEFICIENCY; ARTICLE; CALORIC INTAKE; DIET THERAPY; DIETARY FIBER; DIETARY INTAKE; FAT INTAKE; FEEDING BEHAVIOR; FOOD INTAKE; HEPATOBILIARY SYSTEM INFLAMMATION; HUMAN; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; META ANALYSIS (TOPIC); NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRITIONAL ASSESSMENT; NUTRITIONAL HEALTH; OBESITY; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL (TOPIC); VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; CHEMISTRY; COMPLICATION; DIET; FATTY LIVER; HEALTH BEHAVIOR; LIFESTYLE; NON-ALCOHOLIC FATTY LIVER DISEASE; NUTRITIONAL SCIENCE; PATHOLOGY;

CARBOHYDRATES; CHOLESTEROL; DIET; DIETARY FATS; FATTY ACIDS; FATTY ACIDS, UNSATURATED; FATTY LIVER; FOOD HABITS; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; LIPIDS; NON-ALCOHOLIC FATTY LIVER DISEASE; NUTRITION ASSESSMENT; NUTRITION THERAPY; NUTRITIONAL SCIENCES; OBESITY; PROBIOTICS; VITAMIN D DEFICIENCY; VITAMIN E DEFICIENCY; VITAMINS;

EID: 84894252639     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i7.1756     Document Type: Article

References (145)

1. Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010; 53: 372-384 [PMID: 20494470. DOI: 10.1016/j.jhep.2010.04.008]
2. Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, Srishord M. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011; 9: 524-530. e1; quiz e60 [PMID: 21440669 DOI: 10.1016/j.cgh.2011.03.020]
3. Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr 2006; 43: 413-427 [PMID: 17033514. DOI: 10.4103/1319-3767.74476]
4. Papandreou D, Rousso I, Mavromichalis I. Update on nonalcoholic fatty liver disease in children. Clin Nutr 2007; 26: 409-415 [PMID: 17449148 DOI: 10.1016/j.clnu.2007.02.002]
5. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 2006; 118: 1388-1393 [PMID: 17015527 DOI: 10.1542/peds.2006-1212]
6. Younossi ZM, Baranova A, Ziegler K, Del Giacco L, Schlauch K, Born TL, Elariny H, Gorreta F, VanMeter A, Younoszai A, Ong JP, Goodman Z, Chandhoke V. A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease. Hepatology 2005; 42: 665-674 [PMID: 16116632 DOI: 10.1002/hep.20838]
7. Alisi A, Manco M, Panera N, Nobili V. Association between type two diabetes and non-alcoholic fatty liver disease in youth. Ann Hepatol 2009; 8 Suppl 1: S44-S50 [PMID: 19381124]
8. Huang SC, Yang YJ. Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level. J Pediatr Gastroenterol Nutr 2013; 56: 145-150 [PMID: 22983378 DOI: 10.1097/MPG.0b013e3182722aee]
9. Wiegand S, Keller KM, Röbl M, L'Allemand D, Reinehr T, Widhalm K, Holl RW. Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16,390 overweight or obese children and adolescents. Int J Obes (Lond) 2010; 34: 1468-1474 [PMID: 20531349 DOI: 10.1038/ijo.2010.106]
10. Krawczyk K, Szczesniak P, Kumor A, Jasinska A, Omulecka A, Pietruczuk M, Orszulak-Michalak D, Sporny S, Malecka-Panas E. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH). J Physiol Pharmacol 2009; 60 Suppl 3: 71-75 [PMID: 19996485]
11. Yatsuji S, Hashimoto E, Tobari M, Taniai M, Tokushige K, Shiratori K. Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C. J Gastroenterol Hepatol 2009; 24: 248-254 [PMID: 19032450 DOI: 10.1111/j.1440-1746.2008.05640.x]
12. Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011; 43: 617-649 [PMID: 21039302 DOI: 10.3109/07853890.2010.518623]
13. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231 [PMID: 11961152 DOI: 10.1056/NEJMra011775]
14. Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Kechagias S. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006; 44: 865-873 [PMID: 17006923 DOI: 10.1002/hep.21327]
15. Söderberg C, Stål P, Askling J, Glaumann H, Lindberg G, Marmur J, Hultcrantz R. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 2010; 51: 595-602 [PMID: 20014114 DOI: 10.1002/ hep.23314]
16. Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, Zenari L, Falezza G. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 2005; 54: 3541-3546 [PMID: 16306373 DOI: 10.2337/diabetes.54.12.3541]
17. Toshimitsu K, Matsuura B, Ohkubo I, Niiya T, Furukawa S, Hiasa Y, Kawamura M, Ebihara K, Onji M. Dietary habits and nutrient intake in non-alcoholic steatohepatitis. Nutrition 2007; 23: 46-52 [PMID: 17140767 DOI: 10.1016/ j.nut.2006.09.004]
18. Shi L, Liu ZW, Li Y, Gong C, Zhang H, Song LJ, Huang CY, Li M. The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu. Biomed Environ Sci 2012; 25: 383-391 [PMID: 23026517 DOI: 10.3967/0895-3988.2012.04.00 2]
19. Vajro P, Fontanella A, Perna C, Orso G, Tedesco M, De Vincenzo A. Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr 1994; 125: 239-241 [PMID: 8040771 DOI: 10.1016/S0022-3476(94)70202-0]
20. Andersen T, Gluud C, Franzmann MB, Christoffersen P. Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol 1991; 12: 224-229 [PMID: 2051001 DOI: 10.1016/0168-8278(91)90942-5]
21. Palmer M, Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology 1990; 99: 1408-1413 [PMID: 2210247]
22. Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S, Torimura T, Inuzuka S, Sata M, Tanikawa K. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 1997; 27: 103-107 [PMID: 9252081 DOI: 10.1016/S0168-8278(97)80287-5]
23. Hasegawa T, Yoneda M, Nakamura K, Makino I, Terano A. Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment Pharmacol Ther 2001; 15: 1667-1672 [PMID: 11564008 DOI: 10.1046/j.1365-2036.2001.01083.x]
24. Elias MC, Parise ER, de Carvalho L, Szejnfeld D, Netto JP. Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease. Nutrition 2010; 26: 1094-1099 [PMID: 20022466 DOI: 10.1016/j.nut.2009.09.001]
25. Bugianesi E, Marzocchi R, Villanova N, Marchesini G. Nonalcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment. Best Pract Res Clin Gastroenterol 2004; 18: 1105-1116 [PMID: 15561641 DOI: 10.1016/ j.bpg.2004.06.025]
26. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot 1997; 12: 38-48 [PMID: 10170434 DOI: 10.4278/0890-1171-12.1.38]
27. Prochaska JO, DiClemente CC. Transtheoretical therapy: toward a more integrative model of change. Psychotherapy 1982; 19: 276-288 [DOI: 10.1037/h0088437]
28. Greene GW, Rossi SR. Stages of change for reducing dietary fat intake over 18 months. J Am Diet Assoc 1998; 98: 529-534; quiz 535-536 [PMID: 9597025 DOI: 10.1016/S0002-8223(98)00120-5]
29. Vallis M, Ruggiero L, Greene G, Jones H, Zinman B, Rossi S, Edwards L, Rossi JS, Prochaska JO. Stages of change for healthy eating in diabetes: relation to demographic, eatingrelated, health care utilization, and psychosocial factors. Diabetes Care 2003; 26: 1468-1474 [PMID: 12716806 DOI: 10.2337/ diacare.26.5.1468]
30. Centis E, Moscatiello S, Bugianesi E, Bellentani S, Fracanzani AL, Calugi S, Petta S, Dalle Grave R, Marchesini G. Stage of change and motivation to healthier lifestyle in nonalcoholic fatty liver disease. J Hepatol 2013; 58: 771-777 [PMID: 23201248. DOI: 10.1016/j.jhep.2012.11.031]
31. Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, Fava JL, Wing RR. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010; 51: 121-129 [PMID: 19827166 DOI: 10.1002/hep.23276]
32. D'Zurilla TJ, Goldfried MR. Problem solving and behavior modification. J Abnorm Psychol 1971; 78: 107-126 [PMID: 4938262. DOI: 10.1037/h0031360]
33. Collins RL, Parks GA, Marlatt GA. Social determinants of alcohol consumption: the effects of social interaction and model status on the self-administration of alcohol. J Consult Clin Psychol 1985; 53: 189-200 [PMID: 3998247 DOI: 10.1037/ /0022-006X.53.2.189]
34. Koot BG, van der Baan-Slootweg OH, Tamminga-Smeulders CL, Rijcken TH, Korevaar JC, van Aalderen WM, Jansen PL, Benninga MA. Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement. Arch Dis Child 2011; 96: 669-674 [PMID: 21518734 DOI: 10.1136/adc.2010.199760]
35. Reinehr T, Schmidt C, Toschke AM, Andler W. Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study. Arch Dis Child 2009; 94: 437-442 [PMID: 19224892 DOI: 10.1136/adc.2008.143594]
36. Nobili V, Manco M, Devito R, Di Ciommo V, Comparcola D, Sartorelli MR, Piemonte F, Marcellini M, Angulo P. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 2008; 48: 119-128 [PMID: 18537181 DOI: 10.1002/ hep.22336]
37. Guthrie JF, Lin BH, Frazao E. Role of food prepared away from home in the American diet, 1977-78 versus 1994-96: changes and consequences. J Nutr Educ Behav 2002; 34: 140-150 [PMID: 12047838 DOI: 10.1016/S1499-4046(06)60083-3]
38. Nielsen SJ, Popkin BM. Patterns and trends in food portion sizes, 1977-1998. JAMA 2003; 289: 450-453 [PMID: 12533124 DOI: 10.1001/jama.289.4.450]
39. Ledikwe JH, Ello-Martin JA, Rolls BJ. Portion sizes and the obesity epidemic. J Nutr 2005; 135: 905-909 [PMID: 15795457]
40. Bellisle F, Le Magnen J. The structure of meals in humans: eating and drinking patterns in lean and obese subjects. Physiol Behav 1981; 27: 649-658 [PMID: 7323168 DOI: 10.1016 /0031-9384(81)90237-7]
41. Rolls BJ, Rowe EA, Rolls ET, Kingston B, Megson A, Gunary R. Variety in a meal enhances food intake in man. Physiol Behav 1981; 26: 215-221 [PMID: 7232526 DOI: 10.1016/0031-9 384(81)90014-7]
42. Rolls BJ, Rowe EA, Rolls ET. How sensory properties of foods affect human feeding behavior. Physiol Behav 1982; 29: 409-417 [PMID: 7178247 DOI: 10.1016/0031-9384(82)90259-1]
43. Berry SL, Beatty WW, Klesges RC. Sensory and social influences on ice cream consumption by males and females in a laboratory setting. Appetite 1985; 6: 41-45 [PMID: 3994354 DOI: 10.1016/S0195-6663(85)80049-0]
44. Kechagias S, Ernersson A, Dahlqvist O, Lundberg P, Lindström T, Nystrom FH. Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects. Gut 2008; 57: 649-654 [PMID: 18276725 DOI: 10.1136/gut.2007.131797]
45. Pereira MA, Kartashov AI, Ebbeling CB, Van Horn L, Slattery ML, Jacobs DR, Ludwig DS. Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis. Lancet 2005; 365: 36-42 [PMID: 15639678 DOI: 10.1016/S0140-6736(04)17663-0]
46. Bowman SA, Gortmaker SL, Ebbeling CB, Pereira MA, Ludwig DS. Effects of fast-food consumption on energy intake and diet quality among children in a national household survey. Pediatrics 2004; 113: 112-118 [PMID: 14702458 DOI: 10.1542/peds.113.1.112]
47. STUNKARD AJ, GRACE WJ, WOLFF HG. The night-eating syndrome; a pattern of food intake among certain obese patients. Am J Med 1955; 19: 78-86 [PMID: 14388031]
48. Sookoian S, Gemma C, Fernández Gianotti T, Burgueño A, Alvarez A, González CD, Pirola CJ. Effects of rotating shift work on biomarkers of metabolic syndrome and inflammation. J Intern Med 2007; 261: 285-292 [PMID: 17305651 DOI: 10.1111/j.1365-2796.2007.01766.x]
49. Wang XS, Armstrong ME, Cairns BJ, Key TJ, Travis RC. Shift work and chronic disease: the epidemiological evidence. Occup Med (Lond) 2011; 61: 78-89 [PMID: 21355031 DOI: 10.1093/occmed/kqr001]
50. Lin YC, Chen PC. Persistent Rotating Shift Work Exposure Is a Tough Second Hit Contributing to Abnormal Liver Function Among On-Site Workers Having Sonographic Fatty Liver. Asia Pac J Public Health 2012; Epub ahead of print [PMID: 23239752. DOI: 10.1038/gene.2011.74]
51. Antunes LC, Levandovski R, Dantas G, Caumo W, Hidalgo MP. Obesity and shift work: chronobiological aspects. Nutr Res Rev 2010; 23: 155-168 [PMID: 20122305 DOI: 10.1017/ S0954422410000016]
52. Dallmann R, Weaver DR. Altered body mass regulation in male mPeriod mutant mice on high-fat diet. Chronobiol Int 2010; 27: 1317-1328 [PMID: 20653457 DOI: 10.3109/07420528. 2010.489166]
53. de Castro JM. When, how much and what foods are eaten are related to total daily food intake. Br J Nutr 2009; 102: 1228-1237 [PMID: 19650955 DOI: 10.1017/S0007114509371640]
54. Fuse Y, Hirao A, Kuroda H, Otsuka M, Tahara Y, Shibata S. Differential roles of breakfast only (one meal per day) and a bigger breakfast with a small dinner (two meals per day) in mice fed a high-fat diet with regard to induced obesity and lipid metabolism. J Circadian Rhythms 2012; 10: 4 [PMID: 22587351. DOI: 10.1186/1740-3391-10-4]
55. Andrade AM, Greene GW, Melanson KJ. Eating slowly led to decreases in energy intake within meals in healthy women. J Am Diet Assoc 2008; 108: 1186-1191 [PMID: 18589027 DOI: 10.1016/j.jada.2008.04.026]
56. Sasaki S, Katagiri A, Tsuji T, Shimoda T, Amano K. Selfreported rate of eating correlates with body mass index in 18-y-old Japanese women. Int J Obes Relat Metab Disord 2003; 27: 1405-1410 [PMID: 14574353 DOI: 10.1038/sj.ijo.0802425]
57. Otsuka R, Tamakoshi K, Yatsuya H, Murata C, Sekiya A, Wada K, Zhang HM, Matsushita K, Sugiura K, Takefuji S, OuYang P, Nagasawa N, Kondo T, Sasaki S, Toyoshima H. Eating fast leads to obesity: findings based on self-administered questionnaires among middle-aged Japanese men and women. J Epidemiol 2006; 16: 117-124 [PMID: 16710080 DOI: 10.2188/jea.16.117]
58. Christen AG, Christen JA. Horace Fletcher (1849-1919): "The Great Masticator. ". J Hist Dent 1997; 45: 95-100 [PMID: 9693596]
59. Brownell KD, Farley T, Willett WC, Popkin BM, Chaloupka FJ, Thompson JW, Ludwig DS. The public health and economic benefits of taxing sugar-sweetened beverages. N Engl J Med 2009; 361: 1599-1605 [PMID: 19759377 DOI: 10.1056/ NEJMhpr0905723]
60. Assy N, Nasser G, Kamayse I, Nseir W, Beniashvili Z, Djibre A, Grosovski M. Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can J Gastroenterol 2008; 22: 811-816 [PMID: 18925303]
61. Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM, Johnson RJ, Abdelmalek MF. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 2008; 48: 993-999 [PMID: 18395287 DOI: 10.1016/j.jhep.2008.02.011]
62. Abid A, Taha O, Nseir W, Farah R, Grosovski M, Assy N. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J Hepatol 2009; 51: 918-924 [PMID: 19765850 DOI: 10.1016/j.jhep.2009.05.033]
63. Melanson KJ, Westerterp-Plantenga MS, Saris WH, Smith FJ, Campfield LA. Blood glucose patterns and appetite in time-blinded humans: carbohydrate versus fat. Am J Physiol 1999; 277: R337-R345 [PMID: 10444538]
64. Yamazaki T, Nakamori A, Sasaki E, Wada S, Ezaki O. Fish oil prevents sucrose-induced fatty liver but exacerbates highsafflower oil-induced fatty liver in ddy mice. Hepatology 2007; 46: 1779-1790 [PMID: 17935225 DOI: 10.1002/hep.21934]
65. Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett WC, Hu FB. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middleaged women. JAMA 2004; 292: 927-934 [PMID: 15328324 DOI: 10.1001/jama.292.8.927]
66. Jacobson MF, Brownell KD. Small taxes on soft drinks and snack foods to promote health. Am J Public Health 2000; 90: 854-857 [PMID: 10846500]
67. Powell LM, Chaloupka FJ. Food prices and obesity: evidence and policy implications for taxes and subsidies. Milbank Q 2009; 87: 229-257 [PMID: 19298422 DOI: 10.1111/ j.1468-0009.2009.00554.x]
68. Ross AB, Godin JP, Minehira K, Kirwan JP. Increasing whole grain intake as part of prevention and treatment of nonalcoholic Fatty liver disease. Int J Endocrinol 2013; 2013: 585876 [PMID: 23762052 DOI: 10.1155/2013/585876]
69. McKeown NM, Yoshida M, Shea MK, Jacques PF, Lichtenstein AH, Rogers G, Booth SL, Saltzman E. Whole-grain intake and cereal fiber are associated with lower abdominal adiposity in older adults. J Nutr 2009; 139: 1950-1955 [PMID: 19726588. DOI: 10.3945/jn.108.103762]
70. Katcher HI, Legro RS, Kunselman AR, Gillies PJ, Demers LM, Bagshaw DM, Kris-Etherton PM. The effects of a whole grain-enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome. Am J Clin Nutr 2008; 87: 79-90 [PMID: 18175740]
71. Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr 2012; 142: 1304-1313 [PMID: 22649266 DOI: 10.3945/jn.111.155325]
72. Mellen PB, Walsh TF, Herrington DM. Whole grain intake and cardiovascular disease: a meta-analysis. Nutr Metab Cardiovasc Dis 2008; 18: 283-290 [PMID: 17449231 DOI: 10.1016/ j.numecd.2006.12.008]
73. de Munter JS, Hu FB, Spiegelman D, Franz M, van Dam RM. Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review. PLoS Med 2007; 4: e261 [PMID: 17760498 DOI: 10.1371/journal. pmed.0040261]
74. Nettleton JA, McKeown NM, Kanoni S, Lemaitre RN, Hivert MF, Ngwa J, van Rooij FJ, Sonestedt E, Wojczynski MK, Ye Z, Tanaka T, Garcia M, Anderson JS, Follis JL, Djousse L, Mukamal K, Papoutsakis C, Mozaffarian D, Zillikens MC, Bandinelli S, Bennett AJ, Borecki IB, Feitosa MF, Ferrucci L, Forouhi NG, Groves CJ, Hallmans G, Harris T, Hofman A, Houston DK, Hu FB, Johansson I, Kritchevsky SB, Langenberg C, Launer L, Liu Y, Loos RJ, Nalls M, Orho-Melander M, Renstrom F, Rice K, Riserus U, Rolandsson O, Rotter JI, Saylor G, Sijbrands EJ, Sjogren P, Smith A, Steingrímsdóttir L, Uitterlinden AG, Wareham NJ, Prokopenko I, Pankow JS, van Duijn CM, Florez JC, Witteman JC, Dupuis J, Dedoussis GV, Ordovas JM, Ingelsson E, Cupples L, Siscovick DS, Franks PW, Meigs JB. Interactions of dietary whole-grain intake with fasting glucose-and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies. Diabetes Care 2010; 33: 2684-2691 [PMID: 20693352. DOI: 10.2337/dc10-1150]
75. Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med 2011; 364: 2392-2404 [PMID: 21696306 DOI: 10.1056/NEJMoa1014296]
76. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, Cassader M, David E, Cavallo-Perin P, Rizzetto M. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002; 35: 367-372 [PMID: 11826410 DOI: 10.1053/ jhep.2002.30690]
77. Maron DJ, Fair JM, Haskell WL. Saturated fat intake and insulin resistance in men with coronary artery disease. The Stanford Coronary Risk Intervention Project Investigators and Staff. Circulation 1991; 84: 2020-2027 [PMID: 1934376 DOI: 10.1161/01.CIR.84.5.2020]
78. Feskens EJ, Loeber JG, Kromhout D. Diet and physical activity as determinants of hyperinsulinemia: the Zutphen Elderly Study. Am J Epidemiol 1994; 140: 350-360 [PMID: 8059770]
79. Marshall JA, Bessesen DH, Hamman RF. High saturated fat and low starch and fibre are associated with hyperinsulinaemia in a non-diabetic population: the San Luis Valley Diabetes Study. Diabetologia 1997; 40: 430-438 [PMID: 9112020 DOI: 10.1007/s001250050697]
80. Vessby B, Uusitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, Nälsén C, Berglund L, Louheranta A, Rasmussen BM, Calvert GD, Maffetone A, Pedersen E, Gustafsson IB, Storlien LH. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 2001; 44: 312-319 [PMID: 11317662 DOI: 10.1007/s001250051620]
81. Musso G, Gambino R, De Michieli F, Cassader M, Rizzetto M, Durazzo M, Fagà E, Silli B, Pagano G. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003; 37: 909-916 [PMID: 12668986 DOI: 10.1053/jhep.2003.50132]
82. Utzschneider KM, Bayer-Carter JL, Arbuckle MD, Tidwell JM, Richards TL, Craft S. Beneficial effect of a weight-stable, low-fat/low-saturated fat/low-glycaemic index diet to reduce liver fat in older subjects. Br J Nutr 2013; 109: 1096-1104 [PMID: 22849970 DOI: 10.1017/S0007114512002966]
83. Ha SK, Chae C. Inducible nitric oxide distribution in the fatty liver of a mouse with high fat diet-induced obesity. Exp Anim 2010; 59: 595-604 [PMID: 21030787 DOI: 10.1538/expanim. 59.595]
84. Longato L, Tong M, Wands JR, de la Monte SM. High fat diet induced hepatic steatosis and insulin resistance: Role of dysregulated ceramide metabolism. Hepatol Res 2012; 42: 412-427 [PMID: 22176347 DOI: 10.1111/j.1872-034X.2011.00934.x]
85. Schattenberg JM, Galle PR. Animal models of non-alcoholic steatohepatitis: of mice and man. Dig Dis 2010; 28: 247-254 [PMID: 20460919 DOI: 10.1159/000282097]
86. Zelber-Sagi S, Ratziu V, Oren R. Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol 2011; 17: 3377-3389 [PMID: 21876630 DOI: 10.3748/wjg.v17.i29.3377]
87. Musso G, Cassader M, Rosina F, Gambino R. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 2012; 55: 885-904 [PMID: 22278337 DOI: 10.1007/ s00125-011-2446-4]
88. Papandreou D, Karabouta Z, Rousso I. Are dietary cholesterol intake and serum cholesterol levels related to nonalcoholic Fatty liver disease in obese children? Cholesterol 2012; 2012: 572820 [PMID: 22811894 DOI: 10.1155/2012/572820]
89. Enjoji M, Yasutake K, Kohjima M, Nakamuta M. Nutrition and nonalcoholic Fatty liver disease: the significance of cholesterol. Int J Hepatol 2012; 2012: 925807 [PMID: 22550592 DOI: 10.1155/2012/925807]
90. Yasutake K, Nakamuta M, Shima Y, Ohyama A, Masuda K, Haruta N, Fujino T, Aoyagi Y, Fukuizumi K, Yoshimoto T, Takemoto R, Miyahara T, Harada N, Hayata F, Nakashima M, Enjoji M. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol. Scand J Gastroenterol 2009; 44: 471-477 [PMID: 19058085 DOI: 10.1080/00365520802588133]
91. Kainuma M, Fujimoto M, Sekiya N, Tsuneyama K, Cheng C, Takano Y, Terasawa K, Shimada Y. Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulinresistant fatty liver disease with characteristic fibrosis. J Gastroenterol 2006; 41: 971-980 [PMID: 17096066 DOI: 10.1007/ s00535-006-1883-1]
92. Matsuzawa N, Takamura T, Kurita S, Misu H, Ota T, Ando H, Yokoyama M, Honda M, Zen Y, Nakanuma Y, Miyamoto K, Kaneko S. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 2007; 46: 1392-1403 [PMID: 17929294 DOI: 10.1002/hep.21874]
93. Wouters K, van Gorp PJ, Bieghs V, Gijbels MJ, Duimel H, Lütjohann D, Kerksiek A, van Kruchten R, Maeda N, Staels B, van Bilsen M, Shiri-Sverdlov R, Hofker MH. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 2008; 48: 474-486 [PMID: 18666236 DOI: 10.1002/hep.22363]
94. Higuchi N, Kato M, Shundo Y, Tajiri H, Tanaka M, Yamashita N, Kohjima M, Kotoh K, Nakamuta M, Takayanagi R, Enjoji M. Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. Hepatol Res 2008; 38: 1122-1129 [PMID: 18684130 DOI: 10.1111/j.1872-034X.2008.00382.x]
95. Nakamuta M, Fujino T, Yada R, Yada M, Yasutake K, Yoshimoto T, Harada N, Higuchi N, Kato M, Kohjima M, Taketomi A, Maehara Y, Nakashima M, Kotoh K, Enjoji M. Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease. Int J Mol Med 2009; 23: 603-608 [PMID: 19360318]
96. Cortez-Pinto H, Jesus L, Barros H, Lopes C, Moura MC, Camilo ME. How different is the dietary pattern in nonalcoholic steatohepatitis patients? Clin Nutr 2006; 25: 816-823 [PMID: 16677739 DOI: 10.1016/j.clnu.2006.01.027]
97. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, Webb M, Blendis L, Halpern Z, Oren R. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol 2007; 47: 711-717 [PMID: 17850914. DOI: 10.1016/j.jhep.2007.06.020]
98. U.S. Department of Agriculture, U.S. Department of Health and Human Services. Dietary Guidelines for Americans. 7th ed. Washington, D.C.: U.S. Government Printing Office, 2010. Available from: URL: http://www.health.gov/dietaryguidelines/
99. Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan-2012 version. J Atheroscler Thromb 2013; 20: 517-523 [PMID: 23665881 DOI: 10.5551/jat.15792]
100. Ghafoorunissa A, Rajkumar L, Acharya V. Dietary (n-3) long chain polyunsaturated fatty acids prevent sucroseinduced insulin resistance in rats. J Nutr 2005; 135: 2634-2638 [PMID: 16253960]
101. Teran-Garcia M, Adamson AW, Yu G, Rufo C, Suchankova G, Dreesen TD, Tekle M, Clarke SD, Gettys TW. Polyunsaturated fatty acid suppression of fatty acid synthase (FASN): evidence for dietary modulation of NF-Y binding to the Fasn promoter by SREBP-1c. Biochem J 2007; 402: 591-600 [PMID: 17313375]
102. Sekiya M, Yahagi N, Matsuzaka T, Najima Y, Nakakuki M, Nagai R, Ishibashi S, Osuga J, Yamada N, Shimano H. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 2003; 38: 1529-1539 [PMID: 14647064 DOI: 10.1053/jhep.2003.09028]
103. Levy JR, Clore JN, Stevens W. Dietary n-3 polyunsaturated fatty acids decrease hepatic triglycerides in Fischer 344 rats. Hepatology 2004; 39: 608-616 [PMID: 14999679 DOI: 10.1002/ hep.20093]
104. Capanni M, Calella F, Biagini MR, Genise S, Raimondi L, Bedogni G, Svegliati-Baroni G, Sofi F, Milani S, Abbate R, Surrenti C, Casini A. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment Pharmacol Ther 2006; 23: 1143-1151 [PMID: 16611275 DOI: 10.1111/j.1365-2036.2006.02885.x]
105. Zhu FS, Liu S, Chen XM, Huang ZG, Zhang DW. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. World J Gastroenterol 2008; 14: 6395-6400 [PMID: 19009658 DOI: 10.3748/wjg.14.6395]
106. Spadaro L, Magliocco O, Spampinato D, Piro S, Oliveri C, Alagona C, Papa G, Rabuazzo AM, Purrello F. Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig Liver Dis 2008; 40: 194-199 [PMID: 18054848. DOI: 10.1016/j.dld.2007.10.003]
107. Cussons AJ, Watts GF, Mori TA, Stuckey BG. Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy. J Clin Endocrinol Metab 2009; 94: 3842-3848 [PMID: 19622617 DOI: 10.1210/jc.2009-0870]
108. Iso H, Kobayashi M, Ishihara J, Sasaki S, Okada K, Kita Y, Kokubo Y, Tsugane S. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 2006; 113: 195-202 [PMID: 16401768 DOI: 10.1161/CIRCULATIONAHA. 105.581355]
109. Yamagishi K, Iso H, Date C, Fukui M, Wakai K, Kikuchi S, Inaba Y, Tanabe N, Tamakoshi A. Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study. J Am Coll Cardiol 2008; 52: 988-996 [PMID: 18786479 DOI: 10.1016/ j.jacc.2008.06.018]
110. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998; 114: 842-845 [PMID: 9547102 DOI: 10.1016/ S0016-5085(98)70599-2]
111. Albano E, Mottaran E, Vidali M, Reale E, Saksena S, Occhino G, Burt AD, Day CP. Immune response towards lipid peroxidation products as a predictor of progression of nonalcoholic fatty liver disease to advanced fibrosis. Gut 2005; 54: 987-993 [PMID: 15951547 DOI: 10.1136/gut.2004.057968]
112. Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K, Wakasa K. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 2002; 37: 56-62 [PMID: 12076862 DOI: 10.1016/ S0168-8278(02)00073-9]
113. Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006; 6: 1-28 [PMID: 16406828. DOI: 10.1016/j.mito.2005.10.004]
114. Erhardt A, Stahl W, Sies H, Lirussi F, Donner A, Häussinger D. Plasma levels of vitamin E and carotenoids are decreased in patients with Nonalcoholic Steatohepatitis (NASH). Eur J Med Res 2011; 16: 76-78 [PMID: 21463986 DOI: 10.1186/2047-783X-16-2-76]
115. Horoz M, Bolukbas C, Bolukbas FF, Sabuncu T, Aslan M, Sarifakiogullari S, Gunaydin N, Erel O. Measurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis. BMC Gastroenterol 2005; 5: 35 [PMID: 16283935]
116. Koruk M, Taysi S, Savas MC, Yilmaz O, Akcay F, Karakok M. Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis. Ann Clin Lab Sci 2004; 34: 57-62 [PMID: 15038668]
117. Fierbinţeanu-Braticevici C, Bengus A, Neamţu M, Usvat R. The risk factors of fibrosis in nonalcoholic steatohepatitis. Rom J Intern Med 2002; 40: 81-88 [PMID: 15526543]
118. Videla LA, Rodrigo R, Orellana M, Fernandez V, Tapia G, Quiñones L, Varela N, Contreras J, Lazarte R, Csendes A, Rojas J, Maluenda F, Burdiles P, Diaz JC, Smok G, Thielemann L, Poniachik J. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin Sci (Lond) 2004; 106: 261-268 [PMID: 14556645 DOI: 10.1042/ CS20030285]
119. Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, Neuschwander-Tetri BA, Lavine JE, Tonascia J, Unalp A, Van Natta M, Clark J, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010; 362: 1675-1685 [PMID: 20427778 DOI: 10.1056/NEJMoa0907929]
120. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Glynn RJ, Gaziano JM. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2008; 300: 2123-2133 [PMID: 18997197 DOI: 10.1001/jama.2008.600]
121. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev 2008; (3): CD004183 [PMID: 18677777. DOI: 10.1002/14651858.CD004183.pub3]
122. Sumida Y, Naito Y, Tanaka S, Sakai K, Inada Y, Taketani H, Kanemasa K, Yasui K, Itoh Y, Okanoue T, Yoshikawa T. Long-term (& gt; =2 yr) efficacy of vitamin e for non-alcoholic steatohepatitis. Hepatogastroenterology 2013; 60: 1445-1450 [PMID: 23933938 DOI: 10.5754/hge11421]
123. Han Y, Shi JP, Ma AL, Xu Y, Ding XD, Fan JG. Randomized, vitamin e-controlled trial of bicyclol plus metformin in nonalcoholic Fatty liver disease patients with impaired fasting glucose. Clin Drug Investig 2014; 34: 1-7 [PMID: 24081374 DOI: 10.1007/s40261-013-0136-3]
124. Alvarez JA, Ashraf A. Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010; 2010: 351385 [PMID: 20011094 DOI: 10.1155/2010/351385]
125. Bradlee ML, Singer MR, Qureshi MM, Moore LL. Food group intake and central obesity among children and adolescents in the Third National Health and Nutrition Examination Survey (NHANES III). Public Health Nutr 2010; 13: 797-805 [PMID: 19772691 DOI: 10.1017/S1368980009991546]
126. Smotkin-Tangorra M, Purushothaman R, Gupta A, Nejati G, Anhalt H, Ten S. Prevalence of vitamin D insufficiency in obese children and adolescents. J Pediatr Endocrinol Metab 2007; 20: 817-823 [PMID: 17849744 DOI: 10.1515/JPEM.2007.20.7.817]
127. Roth CL, Elfers CT, Figlewicz DP, Melhorn SJ, Morton GJ, Hoofnagle A, Yeh MM, Nelson JE, Kowdley KV. Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. Hepatology 2012; 55: 1103-1111 [PMID: 21994008 DOI: 10.1002/hep.24737]
128. Manco M, Ciampalini P, Nobili V. Low levels of 25-hydroxyvitamin D(3) in children with biopsy-proven nonalcoholic fatty liver disease. Hepatology 2010; 51: 2229; author reply 2230 [PMID: 20513013 DOI: 10.1002/hep.23724]
129. Wu CC, Chang JH, Chen CC, Su SB, Yang LK, Ma WY, Zheng CM, Diang LK, Lu KC. Calcitriol treatment attenuates inflammation and oxidative stress in hemodialysis patients with secondary hyperparathyroidism. Tohoku J Exp Med 2011; 223: 153-159 [PMID: 21350317 DOI: 10.1620/tjem.223.153]
130. Barchetta I, Carotti S, Labbadia G, Gentilucci UV, Muda AO, Angelico F, Silecchia G, Leonetti F, Fraioli A, Picardi A, Morini S, Cavallo MG. Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. Hepatology 2012; 56: 2180-2187 [PMID: 22753133 DOI: 10.1002/hep.25930]
131. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-1023 [PMID: 17183309 DOI: 10.1038/4441022a]
132. Ma X, Hua J, Li Z. Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J Hepatol 2008; 49: 821-830 [PMID: 18674841 DOI: 10.1016/j.jhep.2008.05.025]
133. Iacono A, Raso GM, Canani RB, Calignano A, Meli R. Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms. J Nutr Biochem 2011; 22: 699-711 [PMID: 21292470 DOI: 10.1016/ j.jnutbio.2010.10.002]
134. Kelishadi R, Farajian S, Mirlohi M. Probiotics as a novel treatment for non-alcoholic Fatty liver disease; a systematic review on the current evidences. Hepat Mon 2013; 13: e7233 [PMID: 23885277 DOI: 10.5812/hepatmon.7233]
135. Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, Desimone C, Song XY, Diehl AM. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003; 37: 343-350 [PMID: 12540784 DOI: 10.1053/jhep.2003.50048]
136. Velayudham A, Dolganiuc A, Ellis M, Petrasek J, Kodys K, Mandrekar P, Szabo G. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. Hepatology 2009; 49: 989-997 [PMID: 19115316 DOI: 10.1002/hep.22711]
137. Lee HY, Park JH, Seok SH, Baek MW, Kim DJ, Lee KE, Paek KS, Lee Y, Park JH. Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. Biochim Biophys Acta 2006; 1761: 736-744 [PMID: 16807088 DOI: 10.1016/ j.bbalip.2006.05.007]
138. Esposito E, Iacono A, Bianco G, Autore G, Cuzzocrea S, Vajro P, Canani RB, Calignano A, Raso GM, Meli R. Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. J Nutr 2009; 139: 905-911 [PMID: 19321579. DOI: 10.3945/jn.108.101808]
139. Karahan N, Işler M, Koyu A, Karahan AG, Başyi{dotless}ǧi{dotless}t Kiliç G, Ci{dotless}ri{dotless}ş IM, Sütçü R, Onaran I, Cam H, Keski{dotless}n M. Effects of probiotics on methionine choline deficient diet-induced steatohepatitis in rats. Turk J Gastroenterol 2012; 23: 110-121 [PMID: 22706738]
140. Wang Y, Xu N, Xi A, Ahmed Z, Zhang B, Bai X. Effects of Lactobacillus plantarum MA2 isolated from Tibet kefir on lipid metabolism and intestinal microflora of rats fed on high-cholesterol diet. Appl Microbiol Biotechnol 2009; 84: 341-347 [PMID: 19444443 DOI: 10.1007/s00253-009-2012-x]
141. Paik HD, Park JS, Park E. Effects of Bacillus polyfermenticus SCD on lipid and antioxidant metabolisms in rats fed a high-fat and high-cholesterol diet. Biol Pharm Bull 2005; 28: 1270-1274 [PMID: 15997112 DOI: 10.1248/bpb.28.1270]
142. Yadav H, Jain S, Sinha PR. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 2007; 23: 62-68 [PMID: 17084593. DOI: 10.1016/j.nut.2006.09.002]
143. Loguercio C, De Simone T, Federico A, Terracciano F, Tuccillo C, Di Chicco M, Cartenì M. Gut-liver axis: a new point of attack to treat chronic liver damage? Am J Gastroenterol 2002; 97: 2144-2146 [PMID: 12190198 DOI: 10.1111/j.1572-0241.2002.05942. x]
144. Loguercio C, Federico A, Tuccillo C, Terracciano F, D'Auria MV, De Simone C, Del Vecchio Blanco C. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol 2005; 39: 540-543 [PMID: 15942443 DOI: 10.1097/01.mcg.0000165671.25272.0f]
145. Aller R, De Luis DA, Izaola O, Conde R, Gonzalez Sagrado M, Primo D, De La Fuente B, Gonzalez J. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. Eur Rev Med Pharmacol Sci 2011; 15: 1090-1095 [PMID: 22013734]